|
MCE 国际站:Bumetanide
中文名:布美他尼
CAS:28395-03-1
品牌:MedChemExpress (MCE)
存储条件:4°C, protect from light
生物活性:布美他尼 (Ro 10-6338; PF 1593) 是一种高效袢利尿剂,是一种 Na+-K+-Cl+ 协同转运蛋白 (NKCC) 阻滞剂。 Bumetanide 是一种选择性 NKCC1 抑制剂,但也抑制 NKCC2,对 hNKCC1A 和 hNKCC2A 的 IC50 分别为 0.68 μM 和 4.0 μM<支持>[1][2]。 IC50 和目标:IC50:0.68 μM (hNKCC1A)、4.0 μM (hNKCC2A)[1]
体外:布美他尼对人类 NKCC 的两种主要剪接变体 hNKCC1A 和 hNKCC2A 具有抑制作用[1]。布美他尼(0.03-100 μM;5 分钟)抑制86Rb+ 在表达 NKCC1A 的卵母细胞中以剂量依赖性方式摄取[1]。布美他尼抑制 HEK-293 细胞中的 NKCC2 亚型 B,具有IC50 值为 0.54 μM[2]。
体内:布美他尼(7.6-30.4 mg/kg;静脉注射)减弱了皮质和纹状体表观扩散系数 (ADC) 比率的降低(降低了 40-67%),表明水肿形成减少[3]。布美他尼还可以减少梗塞面积[3]。布美他尼在 2 mg/kg、8 mg/kg 和大鼠分别静脉注射20 mg/kg[4].
热销产品:1,2,3,19-Tetrahydroxy-12-ursen-28-oic acid | F-15599 | (Pro3) GIP, human (TFA) | MR 409 | SB 242084 | VLX1570 | Vasopressin | Cinacalcet | Anisodamine (hydrobromide) | Valemetostat
研究领域:Membrane Transporter/Ion Channel
作用靶点:NKCC
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献:[1]. Lykke K, et al. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A. Epilepsy Behav. 2016 Jun;59:42-9.
[2]. Ciaran Richardson, et al. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci. 2011 Mar 1;124(Pt 5):789-800.
[3]. Martha E O'Donnell, et al. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab. 2004 Sep;24(9):1046-56.
[4]. S H Lee, et al. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments. J Pharmacokinet Biopharm. 1994 Feb;22(1):1-17.6
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-19 22:03
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社